Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Psychiatry
Volume 2016, Article ID 7901085, 3 pages
http://dx.doi.org/10.1155/2016/7901085
Case Report

Topiramate-Induced Persistent Eyelid Myokymia

Department of Psychiatry, Shafa Hospital, Guilan University of Medical Sciences, Rasht 4165863795, Iran

Received 19 February 2016; Accepted 4 May 2016

Academic Editor: Jaspreet S. Brar

Copyright © 2016 Mohammadrasoul Khalkhali. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. D. Privitera, M. J. Brodie, R. H. Mattson, D. W. Chadwick, W. Neto, and S. Wang, “Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy,” Acta Neurologica Scandinavica, vol. 107, no. 3, pp. 165–175, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. M. A. Abtahi, S. H. Abtahi, F. Fazel et al., “Topiramate and the vision: a systematic review,” Clinical Ophthalmology, vol. 6, pp. 117–131, 2012. View at Publisher · View at Google Scholar
  3. J. W. Fleming, K. S. McClendon, and D. M. Riche, “New obesity agents: lorcaserin and phentermine/topiramate,” Annals of Pharmacotherapy, vol. 47, no. 7-8, pp. 1007–1016, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Singh and R. Kumar, “Phentermine-topiramate: first combination drug for obesity,” International Journal of Applied and Basic Medical Research, vol. 5, no. 2, pp. 157–158, 2015. View at Publisher · View at Google Scholar
  5. S. N. Ghaemi, S. G. Manwani, J. J. Katzow, J. Y. Ko, and F. K. Goodwin, “Topiramate treatment of bipolar spectrum disorders: a retrospective chart review,” Annals of Clinical Psychiatry, vol. 13, no. 4, pp. 185–189, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Stefan, L. Hubbertz, I. Peglau et al., “Epilepsy outcomes in elderly treated with topiramate,” Acta Neurologica Scandinavica, vol. 118, no. 3, pp. 164–174, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. V. Medrano-Martínez, A. Pérez-Sempere, J. M. Moltó-Jordá et al., “Eyelid myokymia in patients with migraine taking topiramate,” Acta Neurologica Scandinavica, vol. 132, no. 2, pp. 143–146, 2015. View at Publisher · View at Google Scholar
  8. S. J. Oh, A. Alapati, G. C. Claussen, and S. Vernino, “Myokymia, neuromyotonia, dermatomyositis, and voltage-gated K+ channel antibodies,” Muscle and Nerve, vol. 27, no. 6, pp. 757–760, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. J. C. Rucker, “Chapter 15—normal and abnormal lid function,” Handbook of Clinical Neurology, vol. 102, pp. 403–424, 2011. View at Publisher · View at Google Scholar
  10. P. J. May, R. G. Baker, and B. Chen, “The eyelid levator muscle: servant of two masters,” Movement Disorders, vol. 17, supplement 2, pp. S4–S7, 2002. View at Publisher · View at Google Scholar
  11. P. J. May and J. D. Porter, “The distribution of primary afferent terminals from the eyelids of macaque monkeys,” Experimental Brain Research, vol. 123, no. 4, pp. 368–381, 1998. View at Publisher · View at Google Scholar · View at Scopus
  12. A. H. Ross, J. S. Elston, M.-H. Marion, and R. Malhotra, “Review and update of involuntary facial movement disorders presenting in the ophthalmological setting,” Survey of Ophthalmology, vol. 56, no. 1, pp. 54–67, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. Á. Esteban, A. Traba, and J. Prieto, “Eyelid movements in health and disease. The supranuclear impairment of the palpebral motility,” Neurophysiologie Clinique, vol. 34, no. 1, pp. 3–15, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Helmchen and H. Rambold, “The eyelid and its contribution to eye movements,” Developments in Ophthalmology, vol. 40, pp. 110–131, 2007. View at Publisher · View at Google Scholar
  15. R. Banik and N. R. Miller, “Chronic myokymia limited to the eyelid is a benign condition,” Journal of Neuro-Ophthalmology, vol. 24, no. 4, pp. 290–292, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. I. K. Hart, P. Maddison, J. Newsom-Davis, A. Vincent, and K. R. Mills, “Phenotypic variants of autoimmune peripheral nerve hyperexcitability,” Brain, vol. 125, no. 8, pp. 1887–1895, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. N. H. Shah and E. Aizenman, “Voltage-gated potassium channels at the crossroads of neuronal function, ischemic tolerance, and neurodegeneration,” Translational Stroke Research, vol. 5, no. 1, pp. 38–58, 2014. View at Publisher · View at Google Scholar · View at Scopus